|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.320 HKD | +1.14% |
|
+3.30% | -32.23% |
| 06-05 | Grand Pharmaceutical Group Limited Declares Final Dividend for the Year Ended 31 December 2025 | CI |
| 04-13 | Grand Pharmaceutical Says Liver Cancer Treatment Reaches Clinical Endpoint | MT |
| Market Cap | 18.63B 2.38B 2.08B 1.92B 1.76B 3.34B 229B 3.39B 22.91B 9B 112B 8.92B 8.73B 386B | P/E 2026 * |
9.85x | P/E 2027 * | 8.9x |
|---|---|---|---|---|---|
| Enterprise Value | 18.63B 2.38B 2.08B 1.92B 1.76B 3.34B 229B 3.39B 22.91B 9B 112B 8.92B 8.73B 386B | EV / Sales 2026 * |
1.4x | EV / Sales 2027 * | 1.26x |
| Free-Float |
23.76% | Yield 2026 * |
4.51% | Yield 2027 * | 5.26% |
| 1 day | +1.14% | ||
| 1 week | +3.30% | ||
| Current month | +13.19% | ||
| 1 month | +7.69% | ||
| 3 months | -21.88% | ||
| 6 months | -32.74% | ||
| Current year | -32.23% |
| 1 week | 5.01 |  | 5.38 |
| 1 month | 4.53 | | 5.42 |
| Current year | 4.53 | | 8.18 |
| 1 year | 4.53 | | 9.89 |
| 3 years | 3.17 | | 10.2 |
| 5 years | 3.17 | | 10.2 |
| 10 years | 1.36 | | 10.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 36 | 2021-05-31 |
Tin Chung Foo
SEC | Corporate Secretary | 57 | 2011-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 63 | 2005-03-20 |
Geng Pei
BRD | Director/Board Member | 66 | 2011-05-11 |
Ye Bi Hu
BRD | Director/Board Member | 62 | 2018-12-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/22/26 | Other | Chairman | 50,000 | 0.0014% | ||
| 4/21/26 | Other | Chief Executive Officer | 58,500 | 0.0016% | ||
| 3/27/26 | Other | Chairman | 60,000 | 0.0017% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.14% | +3.30% | -43.04% | +22.02% | 2.35B | |
| +1.08% | -4.12% | +47.73% | +160.94% | 1,031B | |
| +1.50% | -3.62% | +51.55% | +56.99% | 595B | |
| +3.47% | +0.94% | +32.36% | +87.09% | 431B | |
| +0.42% | -1.16% | +29.43% | +23.64% | 326B | |
| +1.03% | -0.84% | +29.58% | +45.15% | 277B | |
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | |
| +1.59% | +4.89% | -22.56% | -37.35% | 224B | |
| +2.81% | +1.41% | +23.32% | +61.84% | 193B | |
| +3.04% | +0.63% | +23.52% | +75.12% | 164B | |
| Average | +1.60% | -3.20% | +19.29% | +51.92% | 350.66B | |
| Weighted average by Cap. | +1.52% | -4.30% | +34.32% | +79.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.34B 1.7B 1.49B 1.38B 1.26B 2.39B 164B 2.43B 16.4B 6.44B 80.07B 6.39B 6.25B 276B | 14.78B 1.89B 1.65B 1.52B 1.4B 2.65B 182B 2.69B 18.18B 7.14B 88.72B 7.08B 6.92B 306B |
| Net income | 1.91B 244M 213M 197M 181M 343M 23.51B 348M 2.35B 924M 11.48B 916M 896M 39.64B | 2.09B 266M 233M 215M 197M 374M 25.64B 380M 2.57B 1.01B 12.52B 999M 977M 43.23B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | HK$5.320 | +1.14% | 6,497,555 |
| 26-07-15 | HK$5.260 | +1.15% | 6,634,500 |
| 26-07-14 | HK$5.200 | +1.56% | 5,416,500 |
| 26-07-13 | HK$5.120 | +0.99% | 7,705,500 |
| 26-07-10 | HK$5.070 | -0.59% | 4,763,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 512 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
